Bioxytran, Inc. (OTCMKTS:BIXT) Short Interest Up ∞ in August

Bioxytran, Inc. (OTCMKTS:BIXT) saw a significant growth in short interest in August. As of August 14th, there was short interest totaling 130 shares, a growth of ∞ from the July 30th total of 0 shares. Based on an average daily trading volume, of 183,704 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the company’s shares are sold short.

Bioxytran Price Performance

Shares of BIXT opened at $0.02 on Tuesday. The company has a 50-day moving average of $0.02 and a two-hundred day moving average of $0.03. The stock has a market cap of $2.39 million, a price-to-earnings ratio of -0.69 and a beta of 1.99. Bioxytran has a one year low of $0.02 and a one year high of $0.09.

Bioxytran (OTCMKTS:BIXT) last released its quarterly earnings results on Friday, August 14th. The company reported ($0.01) earnings per share (EPS) for the quarter.

About Bioxytran

Bioxytran, Inc is a clinical-stage biotechnology company focused on the development of synthetic oxygen carriers and novel oxygen therapeutics for acute care and chronic disease applications. The company’s proprietary platform is designed to safely deliver therapeutic levels of oxygen to hypoxic tissues, addressing conditions such as ischemia-reperfusion injury, organ transplantation, and traumatic injury. Its lead product candidates target unmet medical needs in cardiovascular and neurological disorders, wound healing, and critical care settings.

Bioxytran’s research pipeline comprises multiple preclinical-stage assets that leverage stabilized perfluorocarbon emulsions to achieve controlled oxygen release.